New pill targets Hard-to-Treat lymphoma in first human trial
NCT ID NCT06393738
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests an experimental drug called ARV-393 in 255 adults with advanced non-Hodgkin's lymphoma that has come back or not responded to other treatments. The drug is taken as a pill and works by breaking down a protein that helps lymphoma grow. The main goals are to check safety and find the right dose, while also seeing if it can shrink tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY (R/R) ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGNew Haven, Connecticut, 06510, United States
-
Clinical Trial Site
RECRUITINGDetroit, Michigan, 48201, United States
-
Clinical Trial Site
RECRUITINGNew Brunswick, New Jersey, 10065, United States
-
Clinical Trial Site
RECRUITINGNew York, New York, 10016, United States
-
Clinical Trial Site
RECRUITINGNew York, New York, 10021, United States
-
Clinical Trial Site
RECRUITINGCleveland, Ohio, 44122, United States
-
Clinical Trial Site
RECRUITINGNashville, Tennessee, 37203, United States
-
Clinical Trial Site
RECRUITINGHouston, Texas, 77030, United States
-
Clinical Trial Site
RECRUITINGToronto, Ontario, M5G 1Z5, Canada
-
Clinical Trial Site
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
-
Clinical Trial Site
RECRUITINGCopenhagen, 2100, Denmark
-
Clinical Trial Site
RECRUITINGOdense C, 5000, Denmark
-
Clinical Trial Site
RECRUITINGEl Palmar, Murcia, 30120, Spain
-
Clinical Trial Site
RECRUITINGPamplona, Navarre, 31008, Spain
-
Clinical Trial Site
RECRUITINGBarcelona, 8908, Spain
-
Clinical Trial Site
RECRUITINGMadrid, 28050, Spain
-
Clinical Trial Site
RECRUITINGSalamanca, 37007, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can a cancer biopsy predict who responds to a new immunotherapy?
- Can a reshaped chemo combo tame lymphoma with fewer side effects?
- Can a cancer drug reboot the immune system after a stem cell transplant?
- New drug cocktail aims to tackle tough lymphoma
- Radiation and immunotherapy team up against hard-to-treat lymphoma